In the last decade workers in numerous laboratories have investigated the possibility that multiple hydroxylasesystemsexist in the liver microsomal fraction. Since cytochrome P-450 is the substrate-binding site of the hydroxylation system (Imai & Sato, 1966) and also determines its specificity (Lu et al., 1972) , most of the studies have been designed to determine whether multiple forms of cytochrome P-450 are present in liver microsomes (microsomal fraction). For example, the metabolism in vitro of a variety of substrates by liver microsomal fraction can be differentially affected by CO, as well as by many inhibitors and stimulators (Conney et al., 1969) . Also, the age-dependent development of hydroxylase activity varies depending on the substrate (Conney et al., 1969) . One interpretation of these results is that the liver microsomes from a single animal contains several different forms of cytochrome P-450. In addition, a comparison of the spectral and catalytic properties of liver microsomes isolated from rats treated with different inducers suggests the existence of multiple forms of cytochrome P-450. For example, the induction of the spectrally distinct cytochrome P-448 and the change in catalytic activity in liver microsomes isolated from rats treated with 3-methylcholanthrene suggest that this cytochrome P-448 may be a different protein from the cytochrome P-450 in microsomes prepared from untreated rats or rats treated with phenobarbital Mannering, 1971 , 19756). These procedures generally involve the solubilization of liver microsomal protein by sodium cholate, eventually followed by column chromatography in the presence of a non-ionic detergent. The group in our laboratory has developed one of these procedures and has purified cytochrome P-450 from phenobarbital-treated rats and cytochrome P-448 from 3-methylcholanthrene-treated rats (step V; Ryan et al., 19756), and cytochrome P-448 from 3-methylcholanthrene-treated rabbits (step V; Kawalek et al., 1975). As shown in Table 1 , purified rat cytochrome P-450, rat cytochrome P-448 and rabbit cytochrome P-448 all differ from one another with respect to either their spectral properties (reduced CO difference spectrum and ethyl isocyanide difference spectrum) or their minimum molecular weights as determined by disc gel electrophoresis in the presence of sodium dodecyl sulphate and mercaptoethanol. A comparison of the substrate specificities of the various cytochrome P-450 preparations (determined in the presence of fixed amounts of NADPH-cytochrome c reductase and phospholipid) shows that benzphetamine is metabolized preferentially by rat cytochrome P-450
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(phenobarbital-treated animals ; step V), whereas benzo[a]pyrene is hydroxylated preferentially by rat cytochrome P-448 (3-methylcholanthrene-treated animals; step V).
Both substrates are poorly metabolized by rabbit cytochrome P-448. During the isolation and purification procedure of the above three forms, an additional form of cytochrome P-450 (step IVA) was separated in each case from the major purified form. Although these forms are not highly purified, their spectral and catalytic properties are quite different from the purified major forms (compare step IVA with step V in Table 1 ).
As shown in Table 2 , at least four fractions of cytochrome P-450 can be separated from the liver microsomes of phenobarbital-or 3-methylcholanthrene-treated Table 1 . Properties of various forms of cytochrome P-450 isolated from rats and rabbits
Step IVA refers to the cytochrome P-450 or P-448 fractions not retained on the DEAE-cellulose column (Ryan et al., 1975a) , and step V refers to the major form of cytochrome P-450 or P-448 after final purification on a CM-cellulose column (Ryan et al., 1975b) . Rats (immature, male, Long-Evans) and rabbits (mature, male, New Zealand White) were treated with either phenobarbital or 3-methylcholanthrene as indicated.
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Step from the liver microsomes of the same animal have been separated from phenobarbitaltreated rabbits (Haugen et al., 1975) and from control and induced rats (Comai & Gaylor, 1973; Ryan et al., 197%) . Purified rat cytochrome P-450 and rat cytochrome P-448 (step IVB; Ryan et al., 19756) have been used to produce antibodies in rabbits (Thomas et al., , 1976 . As shown in Table 3 , antibody against rat cytochrome P-450 interacts very well with rat cytochrome P-450 (phenobarbital-treated animals; step IVB) and mouse cytochrome P-450 (phenobarbital-treated animals ; fraction C), but either cross-reacts poorly or not at all with other cytochrome P-450 species, as judged by double-diffusion analysis. Similarly, antibody against rat cytochrome P-448 is fairly specific for rat cytochrome P-448, indicating that the various cytochrome P-450 preparations are immunologically distinguishable.
The presence of multiple forms of cytochrome P-450 in untreated animals and in induced animals is an important concept, since it would have an effect on the interpretation of the results of drug-metabolism studies with liver microsomes.
Multiple forms of cytochrome P-450 may be responsible for (1) the complexity of Table 2 . Properties of various forms of cytochrome P-450 isolatedfrom micepretreated with either phenobarbital or 3-methylcholanthrene Fractions A, B, C and D refer to the cytochrome fractions isolated from the liver microsomes of 3-methylcholanthrene-treated BsDzFl/J mice by elution from a DEAEcellulose column with buffers containing 5 m~-, 2 0 m~-, 50mM-and 75m~-potassium phosphate buffer, pH 7.7, respectively. After DEAE-cellulose chromatography, fractions A and C from phenobarbital-treated B,,D2Fl/J mice were further fractionated on CMcellulose columns into fractions Al and Az and fractions Cl and C2 by elution with buffers containing 5mM-and 10mM-potassium phosphate buffer, pH 6.5, respectively. All columns were run in the presence of Emulgen 91 1.
Mouse
Mouse ( t Turnover number (nmol of product formed/min per nmol of cytochrome). Table 3 . Reactivity of cytochrome P-450 antibodies with variousspeciesof cytochromeP-450 Abbreviations: PB, phenobarbital-treated animals; 3-MC, 3-methylcholanthrenetreated animals.
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Rabbit cytochrome P-450 (PB; LMz)$ Rabbit cytochrome P-450 (3-MC; step 1VA)t cytochrome P-450, as well as cytochrome P-448, may have completely different substrate specificities or overlapping substrate specificities. Thus a difference in the proportion of these forms in a microsomal preparation could perhaps explain the species, strain, age, tissue and sex differences observed in drug metabolism. Pretreatment of animals with an inducer may result in the induction of one or more forms of cytochrome P-450 present in untreated animals, changing the proportion of the various forms and thus changing the spectral and catalytic properties of the microsomes of the induced animal as compared with the uninduced animal.
On the basis of our results and those of workers in other laboratories, several comments on substrate specificity and multiple forms of cytochrome P-450 seem appropriate.
(1) The catalytic activity of a particular form of cytochrome P-450 cannot be predicted solely from the absorption maximum of its reduced CO difference spectrum.
For example, rat cytochrome P-448 is 10 times better than rabbit cytochrome P-448 in supporting benzo [a] pyrene metabolism despite the similarity of their reduced CO difference spectra.
(2) One cannot classify the different forms of cytochrome P-450 according to the types of reaction catalysed by these enzymes. For example, the N-dealkylation and O-dealkylation of a compound might be catalysed by a single cytochrome P-450 or different forms of cytochrome P-450. Likewise, the hydroxylation of a compound at several different positions might be catalysed by one or several forms of cytochrome P-450.
(3) It is unlikely that a particular form of cytochrome P-450 can metabolize only a limited number of substrates. The substrate specificities of various forms of cytochrome
